Skip to main content
Log in

Improving efficacy and efficiency through the implementation of a new organisational model in a Radiation Oncology Department

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

To evaluate a new organisational model, “process management” (PM), implemented in the Hospital Universitario Virgen de la Victoria (HUVV) compared with traditional models used in other Radiation Oncology Departments (RODs), in terms of efficacy and efficiency.

Methods

The study period ranged from September 2011 to August 2012. Efficacy was assessed, comparing the number of patients attended in first consultation and treated per month, average waiting time from referral to first visit and average waiting time from first visit to treatment. Data were collected from two public hospitals in Andalusia: the HUVV and another Public Hospital in Andalusia (PHA1). Efficiency was assessed comparing the costs per patient attended in first visit and treated at HUVV in 2012 compared with those of a second Public Hospital in Andalusia (PHA2) for 2008. The number of sessions saved using hypofractionation versus classical schemes during the year 2012 in HUVV was estimated, and the money saved was calculated.

Results

In the efficacy analysis, we found significant differences in the average waiting time for first visit, start of treatment, and the number of patients seen and treated annually. After calculating the total cost generated in the ROD, the efficiency analysis showed a lower cost per patient attended in first visit (EUR 599.17) and per patient treated (EUR 783.50), with a saving of 6035 sessions using hypofractionated schemes.

Conclusions

Process management in an ROD reduces time, both to first medical visit and to treatment initiation, allowing an optimisation of linear accelerator (LINAC) capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosenblatt E, Izewska J, Anacak Y, Pynda Y, Scalliet P, Boniol M, et al. RT capacity in European countries: an analysis of the Directory of RT Centres (DIRAC) database. Lancet Oncol. 2013;14(2):e79–86.

    Article  PubMed  Google Scholar 

  2. Downing A, Gilthorpe MS, Dodwell D, Lawrence G, Forman D. Waiting times for RT after breast-conserving surgery and the association with survival: a path analysis. Clin Oncol (R Coll Radiol). 2011;23(7):442–8.

    Article  CAS  Google Scholar 

  3. Kim K, Chie EK, Han W, Noh D-Y, Ha SW. Impact of delayed RT on local control in node-negative breast cancer patients treated with breast-conserving surgery and adjuvant RT without chemotherapy. Tumori. 2011;97(3):341–4.

    PubMed  Google Scholar 

  4. Wyatt RM, Jones BJ, Dale RG. RT treatment delays and their influence on tumour control achieved by various fractionation schedules. Br J Radiol. 2008;81(967):549–63.

    Article  CAS  PubMed  Google Scholar 

  5. Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, et al. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013;49(7):1627–33.

    Article  CAS  PubMed  Google Scholar 

  6. Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Implications of delayed initiation of RT: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. J Thorac Oncol. 2011;6(11):1857–64.

    Article  PubMed  Google Scholar 

  7. Rivera C, Mathiaux J, Haaser T, Becqueret H, Jougon J, Trouette R, et al. Delays in the diagnosis and treatment of lung cancer for patients treated with radiation therapy. Bull Cancer. 2012;99(12):1117–22.

    PubMed  Google Scholar 

  8. Paul C, Carey M, Anderson A, Mackenzie L, Sanson-Fisher R, Courtney R, et al. Cancer patients’ concerns regarding access to cancer care: perceived impact of waiting times along the diagnosis and treatment journey. Eur J Cancer Care Engl. 2012;21(3):321–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Herruzo I, Romero J, Palacios A, Mañas A, Samper P, Bayo E. Libro Blanco SEOR XXI. Análisis de la situación y estrategias de futuro. In Libro blanco de SEOR. 1st ed. Editores Medicos SA (EDIMSA). 2010;53–95.

  10. Peiró M, Barrubés J. New context and old challenges in the healthcare system. Rev Esp Cardiol. 2012;65(7):651–5.

    Article  PubMed  Google Scholar 

  11. Mannino M, Yarnold JR. Shorter fractionation schedules in breast cancer RT: clinical and economic implications. Eur J Cancer. 2009;45(5):730–1.

    Article  PubMed  Google Scholar 

  12. Ko EC, Forsythe K, Buckstein M, Kao J, Rosenstein B. Radiobiological rationale and clinical implications of hypofractionated radiation therapy. Cancer Radiother. 2011;15(3):221–9.

    Article  CAS  PubMed  Google Scholar 

  13. Montero A, Sanz X, Herranz R, Cabrera D, Arenas M, Bayo E. Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions). Breast. 2014;23(4):299–309.

    Article  PubMed  Google Scholar 

  14. Prades J, Algara M, Espinas JA, Farrus B, Arenas M, Reyes V. Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: a mixed-methods study. Radiother Oncol. 2017;123(1):22–8.

    Article  PubMed  Google Scholar 

  15. Pennings PS, Goodman JM. Toward a workable framework. In: Pennings PS, Goodman JM, editors. New perspectives on organizational effetiveness. San Francisco: Jossey-Bass; 1977. p. 146–84.

    Google Scholar 

  16. Calzas A, García I, Goicoetxea J, Ruir FJ, Moyano A, Pablos A, Perez JM, Rosado M. Programa de Control de Gestión Hospitalaria (COANh). Sevilla: Servicio Andaluz de Salud. Consejería de Salud; 1997.

  17. Ballesta AM, Bedini JL, Gaya J, Mas E, Pascual C, Raventós J. Aproximación al cálculo del coste estándar por determinación: unidades relativas de valor (URV). Todo Hosp. 1994;107:43–50.

    Google Scholar 

  18. Porceddu SV, Rosser B, Burmeister BH, Jones M, Hickey B, Baumann K, et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment-"Hypo Trial". Radiother Oncol. 2007;85(3):456–62.

    Article  PubMed  Google Scholar 

  19. Rodrigues G, Videtic GMM, Sur R, Bezjak A, Bradley J, Hahn CA, et al. Palliative thoracic RT in lung cancer: an American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol. 2011;1(2):60–71.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast RT (START) Trial A of RT hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9(4):331–41.

    Article  CAS  PubMed  Google Scholar 

  21. Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2010;78(1):11–8.

    Article  PubMed  Google Scholar 

  22. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M, et al. Long-term results of a randomized trial comparing preoperative short-course RT with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–23.

    Article  CAS  PubMed  Google Scholar 

  23. Kaasa S, Brenne E, Lund JA, Fayers P, Falkmer U, Holmberg M, et al. Prospective randomised multicenter trial on single fraction RT (8 Gy × 1) versus multiple fractions (3 Gy × 10) in the treatment of painful bone metastases. Radiother Oncol. 2006;79(3):278–84.

    Article  PubMed  Google Scholar 

  24. Consejería de Salud. Plan Integral de Oncología 2007-2012. Sevilla: Junta de Andalucía, Consejería de Salud; 2007.

  25. Govijarm R. El desorden sanitario tiene cura. Desde la seguridad del paciente hasta la sostenibilidad del sistema sanitario con la gestión por procesos. 1st ed. Barcelona: Marge Medica Books 2009; 29–53.

  26. Armstrong EG, Barsion SJ. Creating “innovator’s DNA” in health care education. Acad Med. 2013;88(3):343–8.

    Article  PubMed  Google Scholar 

  27. Scoccianti S, Agresti B, Simontacchi G, Detti B, Cipressi S, Iannalfi A, et al. From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for RT. Tumori. 2012;98(6):728–35.

    PubMed  Google Scholar 

  28. Palacios Eito A, Espinosa Calvo M, Mañas Rueda A, de Las Heras M. Radiation oncology: future needs and equipment. Current situation in Spain. Clin Transl Oncol. 2008;10(8):478–85.

    Article  PubMed  Google Scholar 

  29. Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of RT in Spain: a minimal standard of RT resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.

    Article  CAS  PubMed  Google Scholar 

  30. Slotman BJ, Vos PH. Planning of RT capacity and productivity. Radiother Oncol Febrero de. 2013;106(2):266–70.

    Article  Google Scholar 

  31. The START Trialists’ Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.

    Article  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

J. A. Medina and Y. Lupiañez-Perez conceived the study and performed the design. P. Pedrosa, M. Lobato, and Y. Lupiañez-Perez gathered the data. Y. Lupiañez-Perez, J. A. Medina, and J. Gomez-Millan participated in the statistical analysis and interpretation. Y. Lupiañez-Perez and J. Gomez-Millan helped to draft the manuscript.

Corresponding authors

Correspondence to Y. Lupiañez-Perez or J. Gomez-Millan.

Ethics declarations

Availability of data and material

All data generated or analysed during this study are included in this published article.

Conflict of interest

The authors declare that they have no competing interests.

Funding

This study received no funding.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lupiañez-Perez, Y., Gomez-Millan, J., Lobato, M. et al. Improving efficacy and efficiency through the implementation of a new organisational model in a Radiation Oncology Department. Clin Transl Oncol 19, 1375–1381 (2017). https://doi.org/10.1007/s12094-017-1678-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-017-1678-2

Keywords

Navigation